Advisory Board Established by The Black Girl's Guide to Healing Emotional Wounds
January 3, 2025 — The Black Girl's Guide to Healing Emotional Wounds forms Advisory Board to empower Black women with emotional healing resources and support
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
January 3, 2025 — The Black Girl's Guide to Healing Emotional Wounds forms Advisory Board to empower Black women with emotional healing resources and support
January 2, 2025 — Snow shoveling can be dangerous for heart health, warns American Heart Association. Learn about the risks and safety tips to prevent heart-related events during winter activities.
January 2, 2025 — Kessler Topaz Meltzer & Check, LLP files securities class action lawsuit against Applied Therapeutics, Inc. for alleged misconduct related to govorestat trial protocol. Investors urged to take action before February 18, 2025, to potentially recover losses. This news emphasizes the significance of regulatory compliance and transparency in pharmaceutical companies.
January 2, 2025 — ABVC BioPharma secures patent approval in Taiwan for Polygala Extract to treat ADHD, reinforcing its global intellectual property portfolio. The company's innovative treatment targets ADHD core symptoms through Norepinephrine Transporter inhibition, with plans to expand globally and improve outcomes for patients worldwide.
January 2, 2025 — XpertDox partners with Nao Medical to integrate AI medical coding software into revenue cycle management. The collaboration showcases the transformative potential of AI in healthcare, bringing significant financial improvements to Nao Medical.
January 2, 2025 — SaveRxCanada.to launches free shipping for RxSelect program in 2025, offering affordable generic medications to customers worldwide. Save up to 80% on prescription drugs compared to U.S. prices. Learn more about this initiative for enhanced medication access and affordability.
January 2, 2025 — Learn about the critical importance of immediate response to cardiac arrest, the recent HEARTS Act signed by President Biden, and the role of CPR and defibrillators in saving lives. Stay informed and be prepared to take action in emergency situations.
December 31, 2024 — Kessler Topaz Meltzer & Check, LLP files securities class action lawsuit against Cassava Sciences, Inc. for misleading claims about Alzheimer's drug. Investors urged to take action if they suffered losses. Learn more about the case and lead plaintiff process.
December 31, 2024 — Kyverna Therapeutics faces a securities class action lawsuit filed by Kessler Topaz Meltzer & Check, LLP on behalf of investors. The complaint alleges false statements regarding clinical trial data. Investors can seek lead plaintiff representation until February 7, 2025.
December 30, 2024 — Muhdo Health partners with Rgentic in Turkey to distribute genetic testing kits, launching a dedicated Turkish-language website. The exclusive agreement opens doors for Muhdo to expand its presence in the health and wellness market.
December 29, 2024 — South Fork Instruments introduces Kemtrak disposable optical measurement cells for bioprocessing applications, offering precise and contamination-free solutions. These single-use cells address critical measurement needs in chromatographic separation, filtration, and protein concentration monitoring.
December 29, 2024 — Stonegate Capital Partners provides an update on Bio-Path Holdings, Inc. for Q3 2024, emphasizing the company's innovative drug candidates and breakthrough technology in cancer treatment. With a strong IP position and strategic relationships, Bio-Path is poised for success and potential growth in the biopharmaceutical industry.
December 29, 2024 — Kessler Topaz Meltzer & Check, LLP files securities class action lawsuit against Applied Therapeutics, Inc. for alleged misconduct. Investors who purchased securities during specific dates urged to take action before February 18, 2025. Learn more about the case and potential impact on the pharmaceutical industry.
December 28, 2024 — The 'Psychiatry: An Industry of Death' museum in Clearwater, hosted by CCHR, draws over 10,000 visitors and aims to raise awareness about the history of psychiatry and advocate for effective change in mental health laws.
December 27, 2024 — Clene (NASDAQ: CLNN) and its subsidiary, Clene Nanomedicine Inc., received FDA guidance for potential accelerated approval of their lead drug candidate CNM-Au8 in ALS. The guidance followed a Type C meeting where Clene presented additional clinical trial data and analyses. Clene plans to submit an NDA under the accelerated approval pathway in mid-2025.
December 26, 2024 — Learn about the securities class action lawsuit filed by Kessler Topaz Meltzer & Check, LLP against Applied Therapeutics, Inc. Allegations include failure to adhere to trial protocol for the drug candidate govorestat, posing a risk of FDA rejection. Investors have until February 18, 2025, to seek appointment as a lead plaintiff.
December 24, 2024 — Chia-Lin Simmons, CEO of LogicMark, discusses the launch of the new premiere safety smartphone, the Freedom Alert Max, in an interview with Benzinga’s All-Access. LogicMark is a leading provider of personal emergency response systems (PERS), health communications devices, and IoT technologies, aiming to create a connected care platform to keep at-risk populations safe.
December 24, 2024 — Diabetics Trust introduces a Transparency Pledge, setting a new standard in the industry for selling diabetic supplies. The initiative ensures fair payouts, fast payments, and a transparent process, addressing rising healthcare costs and promoting sustainability.
December 24, 2024 — Recent study in New South Wales, Australia reveals significant socioeconomic disparity in cancer patient life expectancy. Urgent need to address healthcare disparities and improve access to early detection, quality treatment, and survivorship care for all patients.
December 24, 2024 — New study in Biomedical Analysis reviews advancements in detection of circRNAs, highlighting their potential as cancer biomarkers. Crucial for understanding disease processes and improving diagnosis and prognosis.